Clinical data | |
---|---|
AHFS/Drugs.com | Monograph |
MedlinePlus | a695031 |
Pregnancy category |
|
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
|
|
CAS Number | |
DrugBank | |
ChemSpider |
|
UNII | |
Chemical and physical data | |
Formula | C1377H2208N382O442S17 |
Molar mass | 31731.9 g/mol |
(what is this?) |
Pegaspargase /pəˈɡæspərɡeɪz/, trade name Oncaspar, is a modified enzyme used as an antineoplastic agent. It is a form of L-asparaginase which has undergone PEGylation. The drug is manufactured by Exelead, Inc.
It is used in the treatment of acute lymphoblastic leukemia.